ALAMEDA, Calif.--(BUSINESS WIRE)--Advanced Cell Technology (ACTC), Inc. (OTCBB:ACTC), applying proprietary human embryonic stem (ES) cell technology to the emerging field of regenerative medicine, will present an overview of its stem cell-based therapeutic development programs and proprietary technologies today at the Rodman & Renshaw 8th Annual Healthcare Conference in New York City.
